Carlos Sialer

Carlos Sialer

Auto-generated profile, based on publicly available information

Carlos Sialer

R&D Department, Ilender Perú S.A., Lima, Peru

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
MMMónica G. Malmierca
Mónica G. Malmierca
LGLorena González-Montes
Lorena González-Montes
Ignacio Pérez-VictoriaIgnacio Pérez-Victoria
Ignacio Pérez-Victoria
CSCarlos Sialer
Carlos Sialer
ABAlfredo F. Braña
Alfredo F. Braña
Jose SalasJose Salas
Jose Salas
Many bioactive natural products are glycosylated compounds in which the sugar components usually participate in interaction and molecular recognition of the cellular target. Therefore, the presence of sugar moieties is important, in some cases essential, for bioactivity. Searching for novel glycosylated bioactive compounds is an important aim in the field of the research for natural products from actinomycetes. A great majority of these sugar moieties belong to the 6-deoxyhexoses and share two common biosynthetic steps catalyzed by a NDP-D-glucose synthase (GS) and a NDP-D-glucose 4,6-dehydratase (DH). Based on this fact, seventy one Streptomyces strains isolated from the integument of ants of the Tribe Attini were screened for the presence of biosynthetic gene clusters (BGCs) for glycosylated compounds. Total DNAs were analyzed by PCR amplification using oligo primers for GSs and DHs and also for a NDP-D-glucose-2,3-dehydratases. Amplicons were used in gene disruption experiments to generate non-producing mutants in the corresponding clusters. Eleven mutants were obtained and comparative dereplication analyses between the wild type strains and the corresponding mutants allowed in some cases the identification of the compound coded by the corresponding cluster (lobophorins, vicenistatin, chromomycins and benzanthrins) and that of two novel macrolactams (sipanmycin A and B). Several strains did not show UPLC differential peaks between the wild type strain and mutant profiles. However, after genome sequencing of these strains, the activation of the expression of two clusters was achieved by using nutritional and genetic approaches leading to the identification of compounds of the cervimycins family and two novel members of the warkmycins family. Our work defines a useful strategy for the identification new glycosylated compounds by a combination of genome mining, gene inactivation experiments and the activation of silent biosynthetic clusters in Streptomyces strains.

24 October 2016 in Journal of Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
SCSimone Cristoni
Simone Cristoni
GDGuglielmo Dusi
Guglielmo Dusi
PBPaolo Brambilla
Paolo Brambilla
Adriana AlbiniAdriana Albini
Adriana Albini
MCmatteo conti
matteo conti
DNDouglas Noonan
Douglas Noonan

18 February 2024 in Poultry Science
Verified
Journal Article
Open access
MCMabel Barreiro Carpio
Mabel Barreiro Carpio
MVM. Alejandro Valdes-Pena
M. Alejandro Valdes-Pena
DMDaniel A. Molina
Daniel A. Molina
SCSandra E.J. Espinoza Cabello
Sandra E.J. Espinoza Cabello
CGCarlos A. Sialer Guerrero
Carlos A. Sialer Guerrero
EIEliana Icochea
Eliana Icochea
Improving productive performance is a daily challenge in the poultry industry. Developing cost-effective additives and strategies that improve performance in antibiotic-free poultry production is critical to maintaining productivity and efficiency. This study evaluates the influence of a commercially available phytogenic feed additive (CA-PFA, that comprises silymarin, betaine and curcumin extracts as main ingredients) and silymarin on commercial broilers' productive performance and liver function with and without carbon tetrachloride (CCl4)-induced liver damage. The experiment was conducted in a completely randomized design, with six treatments, eight replicates, and eight birds per replicate in 18 one-day-old male broilers (Cobb Vantress 500) each; under a 3 × 2 factorial arrangement (3 diets x 2 levels of CCl4, 0 and 1 mL/kg body weight orally). The experimental treatments included 3 diets, commercially recommended doses of CA-PFA (500 mg/kg of feed; this dose provides 70 mg/kg of silymarin, besides the other active ingredients included in the formulation), silymarin (250 mg/kg of feed, containing 28% of active ingredient; this dose provides 70 mg/kg of silymarin as active ingredient) and an additive-free basal diet as a control. A standard commercial silymarin was used as a reference due to its well-known and extensively studied hepatoprotective properties that can mitigate the negative effects of CCl4 in the liver. The data were analyzed as a 2-way ANOVA, and the means showing significant (P ≤ 0.05) differences were then compared using the Post-Hoc Tukey HSD test. No interaction was detected between factors. Exposure to CCl4 had a noticeable detrimental effect on alertness, productive performance, and liver function of broilers without a significant increase in mortality. Including CA-PFA in the diet improved productive performance compared to the basal diet from day 21 to the end of the trial, on day 42. While no influence in feed intake was detected for any treatment, CA-PFA improved body weight gain (BWG) and feed conversion ratio (FCR) significantly (P < 0.05) from day 21 to the end of the trial in healthy and CCl4-exposed birds. The results show that CA-PFA supplementation improves performance parameters in broilers with and without CCl4-induced liver damage, when compared to a basal diet and the addition of a standard commercial silymarin product.

1 October 2013 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
CSCarlos Sialer
Carlos Sialer
IGIgnacio García
Ignacio García
JGJavier González-Sabín
Javier González-Sabín
ABAlfredo F. Braña
Alfredo F. Braña
CMCarmen Méndez
Carmen Méndez
Jose SalasJose Salas
Jose Salas